全球生物技術供應鏈市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

世界のバイオテクノロジー,サプライチェーン市場規模は、2025年の257億4,000万米ドルから、2034年には501億8,000万米ドルに達すると予想されており、2026年から2034年にかけてCAGR 7.7％で成長すると見込まれています。この市場は、バイオテクノロジー企業が製造能力を拡大し、ワクチン、生技藥品、細胞,遺伝子治療、および先進的な治療薬に対する需要の高まりに対応していることから、成長を続けています。バイオテクノロジーのサプライチェーンには、専門的な物流、温度管理された輸送、原料、専用設備、および規制順守が求められます。こうした要件の複雑さにより、企業はより洗練されたサプライチェーン管理戦略の導入を進めています。また、製造および物流業務のアウトソーシングの増加も、市場の拡大に寄与しています。バイオテクノロジーのパイプラインが多様化するにつれ、企業はサプライチェーンの可視性、レジリエンス、および業務効率をこれまで以上に重視するようになっています。

主要な成長要素の一つは、バイオ医薬品や個別化医療の複雑化が進んでいることであり、これらは多くの場合、厳格に管理された保管および輸送条件を必要とします。また、サプライチェーンの混乱を受けて、バイオテクノロジー企業はサプライヤーの多様化、戦略的在庫の維持、およびリアルタイム監視能力の強化を進めています。クラウドプラットフォーム、人工知能、IoTセンサー、予測分析といったデジタル技術は、組織が需要予測や出荷の可視性を向上させるのに役立っています。製品のトレーサビリティや品質保証に関する規制要件も、バイオテクノロジー,エコシステム全体における専門的なサプライチェーン,ソリューションやサービスへの投資をさらに後押ししています。

バイオテクノロジーの生産がさらにグローバル化し、個別化治療が広く受け入れられるようになるにつれ、今後の見通しは明るいものとなっています。各社は、自動化された在庫管理、予測分析、ブロックチェーンを活用したトレーサビリティ、およびインテリジェントな物流プラットフォームへの投資をますます拡大すると予想されます。多くの生物製藥には精密な温度管理が求められるため、コールドチェーンインフラは引き続き主要な投資分野となる見込みです。また、製薬およびバイオテクノロジー製造業の拡大に伴い、新興市場も新たな機会を生み出すと予想されます。製造業者、物流事業者、テクノロジー企業、規制当局間の連携が深まることで、サプライチェーンのレジリエンスがさらに強化され、長期的な市場の発展が後押しされるでしょう。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面而實用的見解。每份報告都包含幾個關鍵組成部分，旨在讓您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競合情勢：主要な市場參與企業について、市場での位置づけ、產品系列、戦略的取り組み、財務実績などを含め、詳細に評価します。競合の動向や主要プレイヤーが採用する戦略に関する貴重な知見を提供します。

市場預測：本部分提供基於數據的市場規模和成長模式展望，預測期為指定時期。它綜合考慮歷史趨勢、當前市場狀況和定量分析，揭示未來發展趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

カスタマイズオプション：本公司では、お客様のご要望に合わせてレポートを柔軟にカスタマイズするサービスを提供しております。これには、追加のセグメンテーション、国別分析、競合他社のプロファイリング、カスタマイズされた資料點、あるいは特定の市場セグメントに焦点を当てた洞察などが含まれ、戦略的な意思決定をより適切に支援いたします。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生技供應鏈市場：依產品/服務分類

• 市場分析、洞察與預測
• 軟體/平台
• 硬體
• 服務

第5章 全球生技供應鏈市場：依產品類型分類

• 市場分析、洞察與預測
• 細胞和基因治療
• 血漿衍生產品
• 生物相似藥和生物製藥
• 疫苗
• 其他

第6章 全球生技供應鏈市場：依供應鏈階段分類

• 市場分析、洞察與預測
• 採購和供應商管理
• 製造業的供給調整
• 包裝和標籤
• 倉儲和庫存管理
• 運輸/配送
• 其他

第7章 全球生技供應鏈市場：依應用分類

• 市場分析、洞察與預測
• 臨床試驗供應鏈管理
• 商業生物製品分銷
• 冷鍊和溫控物流
• API、原料和耗材供應管理
• 序列化、可追溯性和合規性
• 其他

第8章 全球生技供應鏈市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥公司和生技公司
• CDMO 和 CRO
• 學術研究機構
• 其他

第9章 全球生技供應鏈市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Deutsche Post AG
  • United Parcel Service Of America Inc
  • Cencora Inc
  • FedEx Healthcare Solutions
  • Kuehne+Nagel
  • McKesson Corporation
  • Cardinal Health
  • Thermo Fisher Scientific Inc
  • Catalent Inc
  • AP Moller-Maersk
  • DB Schenker
  • CEVA Logistics
  • DSV A/S
  • GXO Logistics
  • SF Express
  • Cryoport Inc
  • Marken
  • World Courier
  • DHL Global Forwarding
  • Lineage Logistics

The global biotech supply chain market size is expected to reach USD 50.18 Billion in 2034 from USD 25.74 Billion in 2025, growing at a CAGR of 7.7% during 2026-2034.This market is growing as biotechnology companies expand manufacturing capabilities and respond to increasing demand for vaccines, biologics, cell and gene therapies, and advanced therapeutics. Biotech supply chains require specialized logistics, temperature-controlled transportation, raw materials, specialized equipment, and regulatory compliance. The complexity of these requirements is encouraging companies to adopt more sophisticated supply chain management strategies. Increasing outsourcing of manufacturing and logistics activities is also contributing to market expansion. As biotechnology pipelines become more diversified, companies are placing greater emphasis on supply chain visibility, resilience, and operational efficiency.

One of the key growth drivers is the increasing complexity of biologics and personalized medicines, which often require highly controlled storage and transportation conditions. Supply chain disruptions have also encouraged biotechnology companies to diversify suppliers, maintain strategic inventories, and strengthen real-time monitoring capabilities. Digital technologies such as cloud platforms, artificial intelligence, Internet of Things sensors, and predictive analytics are helping organizations improve demand forecasting and shipment visibility. Regulatory requirements surrounding product traceability and quality assurance further support investment in specialized supply chain solutions and services across the biotechnology ecosystem.

Future prospects are promising as biotechnology production becomes more globalized and personalized therapies gain wider acceptance. Companies are expected to invest increasingly in automated inventory management, predictive analytics, blockchain-enabled traceability, and intelligent logistics platforms. Cold-chain infrastructure is likely to remain a major area of investment because many biological products require precise temperature control. Emerging markets are also expected to create new opportunities as pharmaceutical and biotechnology manufacturing expands. Greater collaboration among manufacturers, logistics providers, technology companies, and regulators will further strengthen supply chain resilience and support long-term market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Offering

• Software/Platforms
• Hardware
• Services

By Product Type

• Cell & Gene Therapies
• Plasma-Derived Products
• Biosimilars & Biologics
• Vaccines
• Others

By Supply Chain Stage

• Procurement & Supplier Management
• Manufacturing Supply Coordination
• Packaging & Labeling
• Warehousing & Inventory Management
• Transportation & Distribution
• Others

By Application

• Clinical Trial Supply Chain Management
• Commercial Biologics Distribution
• Cold Chain & Temperature-Controlled Logistics
• API, Raw Material & Consumables Supply Management
• Serialization, Traceability & Compliance
• Others

By End User

• Pharmaceutical Companies & Biotechnology Companies
• CDMOs & CROs
• Academic & Research Institutes
• Others

COMPANIES PROFILED

• Deutsche Post AG, United Parcel Service of America Inc., Cencora Inc., FedEx Healthcare Solutions, Kuehne+Nagel, McKesson Corporation, Cardinal Health, Thermo Fisher Scientific Inc., Catalent Inc., A.P. Moller - Maersk, DB Schenker, CEVA Logistics, DSV A/S, GXO Logistics, SF Express, Cryoport Inc., Marken, World Courier, DHL Global Forwarding, Lineage Logistics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY OFFERING 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Offering
• 4.2. Software/Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product Type
• 5.2. Cell & Gene Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plasma-Derived Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biosimilars & Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY SUPPLY CHAIN STAGE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Supply Chain Stage
• 6.2. Procurement & Supplier Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Manufacturing Supply Coordination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Packaging & Labeling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Warehousing & Inventory Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Transportation & Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Clinical Trial Supply Chain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Commercial Biologics Distribution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cold Chain & Temperature-Controlled Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. API, Raw Material & Consumables Supply Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Serialization, Traceability & Compliance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Pharmaceutical Companies & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. CDMOs & CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOTECH SUPPLY CHAIN MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Offering
  • 9.2.2 By Product Type
  • 9.2.3 By Supply Chain Stage
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Offering
  • 9.3.2 By Product Type
  • 9.3.3 By Supply Chain Stage
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Offering
  • 9.4.2 By Product Type
  • 9.4.3 By Supply Chain Stage
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Offering
  • 9.5.2 By Product Type
  • 9.5.3 By Supply Chain Stage
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Offering
  • 9.6.2 By Product Type
  • 9.6.3 By Supply Chain Stage
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL BIOTECH SUPPLY CHAIN INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Deutsche Post AG
  • 11.2.2 United Parcel Service Of America Inc
  • 11.2.3 Cencora Inc
  • 11.2.4 FedEx Healthcare Solutions
  • 11.2.5 Kuehne+Nagel
  • 11.2.6 McKesson Corporation
  • 11.2.7 Cardinal Health
  • 11.2.8 Thermo Fisher Scientific Inc
  • 11.2.9 Catalent Inc
  • 11.2.10 A.P. Moller - Maersk
  • 11.2.11 DB Schenker
  • 11.2.12 CEVA Logistics
  • 11.2.13 DSV A/S
  • 11.2.14 GXO Logistics
  • 11.2.15 SF Express
  • 11.2.16 Cryoport Inc
  • 11.2.17 Marken
  • 11.2.18 World Courier
  • 11.2.19 DHL Global Forwarding
  • 11.2.20 Lineage Logistics